Pharmacotherapy Flashcards

Exam Prep

1
Q

Antipsychotic drug indications.

A
  1. Schizophrenia, schizoaffective disorder, delusional disorder
  2. Bipolar disorder (especially manic phase)
  3. Major depression with psychotic features
  4. Some autism or Tourette’s syndrome
  5. Psychosis associated with dementia or delirium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antipsychotic drug mechanisms of action.

A
  1. Dopamine receptor blockers in the CNS
  2. G-protein coupled receptors
  3. Antipsychotic effect through blockade of post-synaptic D2 receptors
  4. Blockade leads to up-regulation of dopamine receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The four dopaminergic pathways.

A
  1. Mesolimbic pathway
  2. Mesocortical pathway
  3. Nigrostriatal pathway
  4. Tubuloinfundibular pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dopamine blockades clinical effect on the dopaminergic pathways.

A
  1. Mesolimbic pathway: improves positive psychotic symptoms.
  2. Mesocortical pathway: worsens cognition and negative symptoms.
  3. Nigrostriatal pathway: extrapyramidal side effects.
  4. Tubuloinfundibular pathway: increased prolactin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Antipsychotic drug classes.

A
  1. 1st Generation - Typical
  2. 2nd Generation - Atypical
  3. 3rd Generation (not recognised) partial D2 antagonists.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Generic names of (3) 1st Generation (Typical) antipsychotic drugs.

A
  1. Haloperidol
  2. Chlorpromazine
  3. Pericyazine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Generic names of (5) 2nd Generation (Atypical) antipsychotic drugs.

A
  1. Aripiprazole
  2. Clozapine
  3. Olanzapine
  4. Quetiapine
  5. Risperidone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Extrapyramidal Side Effects

A
  1. Dystonia
  2. Akathisia
  3. Parkinsonism
  4. Tardive dyskinesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management plan for onset of Extrapyramidal Side Effects.

A
  1. Reduce the dose or change antipsychotic.
  2. Consider anticholinergic agents Benzotropine and Benzhexol to treat dystonia and parkinsonism.
  3. Anticholinergics are ineffective for akathisia and tardive dyskinesia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benzotropine dosage for extrapyramidal side effects.

A
  1. Dystonia; 2mg IM intial then PRN

2. Parkinsonism; 1-2 mg PO BD or TDS (half dose for elderly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Metabolic adverse effects of antipsychotic medications.

A
  1. Weight gain
  2. Hyperglycaemia
  3. Hyperlipidaemia
  4. Glucose intolerance and diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Other adverse effects of antipsychotic medications.

A
  1. Sedation
  2. Postural hypotension.
  3. Constipation
  4. Hyperprolactinaemia
  5. Neuroleptic malignant syndrome.
  6. Prolongation of the QTc interval and sudden cardiac death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Potential adverse effects of hyperprolactinaemia with antipsychotic medication use.

A
  1. Amenorrhoea
  2. Galactorrhoea
  3. Gynaecomastia
  4. Erectile dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Additional adverse effects of Clozapine.

A
  1. Agranulocytosis.
  2. Myocarditis.
  3. Smoking induces livers metabolism clozapine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Blood tests for Clozapine.

A
  1. WBC’s and Serum Clozapine Levels
  2. Weekly for first 18 weeks and then monthly
  3. WBC must be greater than 3.5x 10-9L and neutrophils greater than 2.0x 10-9L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The 4 common broad actions of benzodiazepines.

A
  1. Anxiolytic
  2. Sedative-hypnotic
  3. Anticonvulsant
  4. Muscle relaxant
17
Q

Generic names for short acting benzodiazepines.

A
  1. Lorazepam

2. Temazepam

18
Q

Generic names for long acting benzodiazepines.

A
  1. Clonazepam

2. Diazepam

19
Q

Class effects of benzodiazepines.

A
  1. Drowsiness and cumulative sedation
  2. Ataxia, dizziness
  3. Respiratory depression
  4. Ante-retrograde amnesia
  5. Disinhibition
20
Q

Class interactions of benzodiazepines.

A
  1. Increased effect with other CNS depressants
  2. Ataxia and dysarthria with Lithium and antipsychotics
  3. Delirium with Clozapine
  4. Increases plasma concentrations of digoxin and phenytoin
21
Q

The 2 drug classes used for cognitive impairment in dementia.

A
  1. Cholinesterase inhibitors aka (acetylcholinesterase inhibitors)
  2. N-methyl-D-aspartate (NMDA) agonist
22
Q

The 3 cholinesterase inhibitors used to treat cognitive impairment in dementia.

A
  1. Donepezil
  2. Rivastigmine
  3. Galantamine
23
Q

The NMDA agonist used as a potential adjunct therapy in dementia.

A
  1. Memantine
24
Q

The mechanism of action for cholinesterase inhibitors.

A
  1. Prevents acetlycholinesterase (enzyme) from breaking down acetlycholine (neurotransmitter) into choline and acetate.
  2. This increases the levels of acetlycholine within the synaptic cleft.
25
Q

Common class adverse effects of cholinesterase inhibitors.

A
  1. Increased dreams
  2. Anorexia, nausea, vomiting, diarrhoea
  3. Bronchoconstriction
  4. Muscle cramps
  5. Bradycardia, heart block, syncope
26
Q

Clinical approach to starting cholinesterase inhibitors for dementia.

A
  1. Confirm probable diagnosis
  2. Baseline cognitive function - MMSE 10-24
  3. Check for history of PUD or GI problems
  4. Select appropriate medication
  5. Warn of potential side effects.
  6. Arrange later review.
27
Q

First line medication (cholinesterase inhibitor) for dementia.

A
  1. Donepezil
28
Q

What is the preferred medication (cholinesterase inhibitor) choice if there is a history of significant GI disease in the dementia patient.

A
  1. Rivastigmine (transdermal patch)
29
Q

Indications for antipsychotic medications in patients with dementia.

A
  1. Severe agitation and aggression with risk of harm.
  2. Delusions and hallucinations.
  3. Co-morbid pre-existing mental health conditions.
30
Q

What antipsychotic is currently the recommended first-line choice for behavioural and psychological symptoms of dementia.

A
  1. Risperidone.
31
Q

Specific risks associated with antipsychotic use in dementia patients.

A
  1. Increased risk of cerebrovascular events.
32
Q

Common SSRI’s

A
  1. Sertaline
  2. Citalopram
  3. Escitalopram
  4. Fluoxetine
33
Q

Common SNRI’s

A
  1. Venlafaxine

2. Duloxetine

34
Q

Common NaSSA’s (Noradrenaline and specific serotonergic antidepressants)

A
  1. Mirtazapine

2. Mianserin

35
Q

Common TCA

A
  1. Amitriptyline